Detalhe da pesquisa
1.
Only the beginning: 50 years of progress toward curing childhood cancer.
Cell
; 187(7): 1584-1588, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552608
2.
Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Cancer
; 129(9): 1384-1393, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36829303
3.
Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 70 Suppl 6: e30585, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37489549
4.
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
Pediatr Blood Cancer
; 70(11): e30609, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553297
5.
Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 69(12): e29999, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36215217
6.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer
; 69(11): e29901, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35989458
7.
A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy.
Pediatr Blood Cancer
; 68(10): e29226, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245214
8.
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
Pediatr Blood Cancer
; 68(2): e28787, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140540
9.
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 325(9): 833-842, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651090
10.
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.
Invest New Drugs
; 38(4): 1156-1165, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31734832
11.
Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia.
Pediatr Blood Cancer
; 67(10): e28398, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735397
12.
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG.
Haematologica
; 104(5): 986-992, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545921
13.
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts.
Am J Hematol
; 94(2): 257-265, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30394566
14.
Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies.
Br J Clin Pharmacol
; 85(3): 530-539, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30428505
15.
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Cancer
; 124(6): 1150-1159, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266189
16.
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.
Ann Surg Oncol
; 25(3): 768-775, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28887726
17.
Eliminating disparities improves outcomes.
Blood
; 137(4): 439-441, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507300
18.
Children's Oncology Group's 2023 blueprint for research.
Pediatr Blood Cancer
; 70 Suppl 6: e30569, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433635
19.
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(7): e27062, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603593
20.
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.
Future Oncol
; 14(21): 2115-2129, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29595064